| Drug name | Commercial name | Class | Company | FDA-approved indication |
---|---|---|---|---|---|
Epigenetic Writers | Azacitidine | Vidaza | DNMTi | Celgene Corp | AML, CML, MDS |
5-Aza-2′-deoxycytadine | Dacogen | DNMTi | Eisai | AML, CML, MDS | |
Tazemetostat | Tazverik | HMTi | Epizyme Inc | Epithelioid Sarcoma* | |
Epigenetic Erasers | Panobinostat | Farydak | HDACi | Novartis | Multiple Myeloma |
Vorinostat | Zolinza | pan-HDACi | Merk | CTCL | |
Belinostat | Beleodaq | pan-HDACi | Spectrum pharmaceuticals | PTCL | |
Romidepsin | Istodax | Class I HDACi | Celgene | CTCL/PTCL | |
Chidamide | Epidaza | pan-HDACi | Chipscreen Biosciences | PTCL |